[Orforglipron] has potential to open access [to GLP-1 therapy] to more people because it is easier to take and is simpler to produce, and in theory should be less expensive, Julio Rosenstock, MD, FACE, senior scientific advisor for Velocity Clinical Research, director of Velocitys site at Medical City Dallas and clinical professor of medicine at the University of Texas Southwestern Medical Center, Dallas, said during a press conference
Beyond proximity labeling and EM, LaccID may have utility in other areas
In rare cases, abnormal TSH levels are a reflection of problems with the pituitary gland rather than the thyroid
In This Article What the TrumpRX Deal Actually Says If your insurance covers GLP-1 medications, youre likely already receiving a substantial discount
Comparing Mounjaro with other weight-management drugs has also been telling
To truly support your heart health and maintain healthy blood pressure, you should consider how your various supplements work together